• Home
  •    |   
  • Contact Us
Semprus
     

  • About Us  
    • Company Background
    • Leadership
    • Scientific Advisory Board
    • Current Investors
    • Code of Ethics
    • Affiliations and
      Associations
    • Contact Us
  • |

  •   Market Overiew  
    • Semprus Platform
    • Market Dynamics
  • |

  •   Vascular Access  
    • Semprus Sustain™ Technology
  • |

  •   Future Applications  
    • Pipeline
  • |

  •  Media
Delivering paradigm-shifting medical technologies to improve patient outcomes and reduce complications associated with medical device implants.

Facebook Twitter LinkedIn

NEWS

Semprus in Contact Lens Spectrum Newsletter
(news release)


Christopher Loose named Keynote Speaker at OrthoTec 2012 Conference
(news release)


David Lucchino in Financial Times Article
(news release)


David Lucchino Elected to MassBio Board
(news release)

Semprus Selected as One of  “50 Companies To Watch” in MD+DI Magazine


©2012 Semprus BioSciences
  • Terms of Service
  • |
  • Site Map